dextroamphetamine has been researched along with pramipexole in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jimenez-Gomez, C; Osentoski, A; Woods, JH | 1 |
Adlard, PA; Castro-Hernández, J; Finkelstein, DI | 1 |
1 review(s) available for dextroamphetamine and pramipexole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dextroamphetamine and pramipexole
Article | Year |
---|---|
Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Benzothiazoles; Carbolines; Central Nervous System Stimulants; Compulsive Behavior; Convulsants; Dextroamphetamine; Diazepam; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Obsessive-Compulsive Disorder; Pramipexole; Reproducibility of Results | 2011 |
Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzothiazoles; Dextroamphetamine; Disease Models, Animal; Dopamine; Hippocampus; Humans; Long-Term Potentiation; Mice; Parkinson Disease; Pramipexole; Substantia Nigra; Synaptic Transmission; Temporal Lobe; Ventral Tegmental Area | 2017 |